We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$47.3B
AUM Growth
+$3.18B
Cap. Flow
+$116M
Cap. Flow %
0.24%
Top 10 Hldgs %
11.39%
Holding
2,836
New
148
Increased
1,004
Reduced
1,103
Closed
268

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$541M
2
QCOM icon
Qualcomm
QCOM
+$532M
3
CVX icon
Chevron
CVX
+$514M
4
COP icon
ConocoPhillips
COP
+$495M
5
COR icon
Cencora
COR
+$473M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$559M
2
GILD icon
Gilead Sciences
GILD
+$542M
3
LNG icon
Cheniere Energy
LNG
+$523M
4
LYB icon
LyondellBasell Industries
LYB
+$457M
5
VTRS icon
Viatris
VTRS
+$441M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.84%
2 Technology 17.7%
3 Energy 16.46%
4 Industrials 10.01%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALEC icon
1326
Alector
ALEC
$167M
-572
Closed -$2.6K
ALLO icon
1327
Allogene Therapeutics
ALLO
$576M
-2,372
Closed -$5.53K
ALNY icon
1328
Alnylam Pharmaceuticals
ALNY
$38.2B
-461
Closed -$112K
ALT icon
1329
Altimmune
ALT
$609M
-1,260
Closed -$8.38K
AMCX icon
1330
AMC Global Media
AMCX
$450M
-10,200,388
Closed -$98.5M
AMN icon
1331
AMN Healthcare
AMN
$1.32B
-1,939,268
Closed -$99.3M
AMWD
1332
DELISTED
American Woodmark
AMWD
-843,195
Closed -$66.3M
ANAB icon
1333
AnaptysBio
ANAB
$1.57B
-283
Closed -$7.09K
APGE icon
1334
Apogee Therapeutics
APGE
$10.1B
-426
Closed -$16.8K
APLS
1335
DELISTED
Apellis Pharmaceuticals
APLS
-1,376
Closed -$52.8K
ARCT icon
1336
Arcturus Therapeutics
ARCT
$160M
-444
Closed -$10.8K
ARDX icon
1337
Ardelyx
ARDX
$1.25B
-3,656
Closed -$27.1K
ARQT icon
1338
Arcutis Biotherapeutics
ARQT
$3.46B
-1,476
Closed -$13.7K
ATXS
1339
DELISTED
Astria Therapeutics
ATXS
-613
Closed -$5.58K
AVXL icon
1340
Anavex Life Sciences
AVXL
$234M
-1,276
Closed -$5.38K
AWI icon
1341
Armstrong World Industries
AWI
$7.93B
-1,539
Closed -$174K
BAH icon
1342
Booz Allen Hamilton
BAH
$8.52B
-176
Closed -$27.1K
BBIO icon
1343
BridgeBio Pharma
BBIO
$16.4B
-1,545
Closed -$39.1K
BCC icon
1344
Boise Cascade
BCC
$2.87B
-1,239,115
Closed -$148M
BCRX icon
1345
BioCryst Pharmaceuticals
BCRX
$2.44B
-2,649
Closed -$16.4K
BEAM icon
1346
Beam Therapeutics
BEAM
$2.56B
-940
Closed -$22K
BHVN icon
1347
Biohaven
BHVN
$2.11B
-1,113
Closed -$38.6K
BNTX icon
1348
BioNTech
BNTX
$23.1B
-1,105
Closed -$88.8K
BPMC
1349
DELISTED
Blueprint Medicines
BPMC
-540
Closed -$58.2K
CABA icon
1350
Cabaletta Bio
CABA
$435M
-589
Closed -$4.41K

Similar funds

Pacer Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Pacer Advisors held 2,836 positions worth $47.3B, up 7.2% from $44.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pacer Advisors's Q3 2024 filing shows 148 new, 1,004 increased, 1,103 reduced and 268 closed positions. Its largest new stake was TechnipFMC: 7,077,502 shares worth $186M. The largest sale was 3M, an estimated $559M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

  • Pacer Advisors's largest Q3 2024 buy was TechnipFMC: 7,077,502 shares worth $186M.
  • Pacer Advisors added most to Airbnb in Q3 2024, an estimated $541M increase.
  • Pacer Advisors's biggest Q3 2024 reduction was 3M, cutting an estimated $559M.
  • Pacer Advisors fully exited Newell Brands in Q3 2024, selling an estimated $301M.
  • Pacer Advisors's ten largest holdings make up 11% of its $47.3B portfolio in Q3 2024.
  • Pacer Advisors opened 148 new positions and closed 268 in Q3 2024.
  • Pacer Advisors's portfolio value rose 7.2% quarter-over-quarter to $47.3B.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.